View Document Preview and Link Document Date: 2004-10-28 15:24:22 Open Document File Size: 135,13 KB Share Result on Facebook
City Dr. Frye / New Orleans / Wolfersdorf / Los Angeles / Washington / / Company Eli Lilly / Pfizer / GlaxoSmithKline / Abbott / Eli Lilly and Company / Mallinger AG / Forest Laboratories / Janssen / American Psychiatric Press / Bristol-Myers Squibb / / / Facility UCLA Medical Plaza / / / IndustryTerm received travel assistance / treatment for depression / treatment of unipolar major depressive disorder / treatment of affective disorders / / MedicalCondition thyroid disease / hypothyroidism / bipolar depression / unipolar major depressive disorder / psychiatric disorders / primary depressive illness / subclinical hypothyroidism / manias / Illness / affective disorders / MS / depression / Mental Disorders / / Organization Department of Psychiatry / American Psychiatric Association in Chicago / UCLA / UCLA School of Medicine / Department of Health / Department of Endocrinology / / Person Stanley Korenman / Mark A. Frye / Michael Bauer / Rita Suri / Lynn Fairbanks / Michael Gitlin / Emily L. Huynh / Lori L. Altshuler / / Position editor / speaker / Joffe RT / Levitt AJ / consultant / Joffe RT / Sokolov STH / Joffe RT / Singer / / Product fluoxetine / / ProvinceOrState Nova Scotia / California / / Technology CGI / / SocialTag 
Research Paper Article de recherche Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors Michael Gitlin, MD; Lori L. Altshuler, MD; Mark A. Frye, MD; Rita Suri, MD;